Your browser doesn't support javascript.
loading
Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants.
Hubbard, Caleb; Benda, Erica; Hardin, Tyler; Baxter, Taylor; St John, Elizabeth; O'Brien, Sean; Hensley, Kenneth; Holgado, Andrea M.
Afiliación
  • Hubbard C; Department of Biological Sciences, Southwestern Oklahoma State University, Weatherford, Oklahoma, USA.
J Neurosci Res ; 91(9): 1183-90, 2013 Sep.
Article en En | MEDLINE | ID: mdl-23825043
ABSTRACT
Lanthionine ketimine (LK) is a natural sulfur amino acid metabolite with potent neurotrophic activity. Proteomics indicate that LK interacts with collapsin response mediator protein-2 (CRMP2/DPYSL2/UNC-33), a brain-enriched protein that was shown to regulate cytoskeletal remodeling, neuronal morphology, and synaptic function. To elucidate further the molecular interplay and biological action of LK and UNC-33, we began examining the nervous system of Caenorhabditis elegans nematodes in which both LK concentrations and UNC-33 protein were manipulated. To this end, a cell-permeable LK-ester (LKE) was administered to developing C. elegans engineered to express yellow fluorescent protein (YFP) in cholinergic neurons (strain RM3128) or green fluorescent protein (GFP) in GABAergic neurons (strain CZ1200), and neural morphology was assessed. Fluorescent imaging analyses show that LKE exposure to wild-type animals induced neural commissure outgrowth, crossing over, and bundling in both neurites from GABAergic and cholinergic motor neurons. Additionally, when unc-33(e204) hypomorph mutant nematodes (D389N substitution mutants) were exposed to LKE, both the neuroanatomical defects of incomplete dorsoventral neural commissures and the ventral nerve cord gaps were partially rescued. In contrast, LKE did not rescue ventral nerve cord gaps found in unc-33(mn407) null mutant. Together these data suggest possible functions for LK as a regulator of neuritic elongation, corroborate roles for UNC-33/CRMP2 in the mechanism of LKE activity, and suggest the potential of LKE as a therapeutic molecule for neurological diseases involving CRMP2 dysfunction.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encefalopatías / Discapacidades del Desarrollo / Fármacos Neuroprotectores / Proteínas de Caenorhabditis elegans / Aminoácidos Sulfúricos / Mutación / Factores de Crecimiento Nervioso Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Neurosci Res Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encefalopatías / Discapacidades del Desarrollo / Fármacos Neuroprotectores / Proteínas de Caenorhabditis elegans / Aminoácidos Sulfúricos / Mutación / Factores de Crecimiento Nervioso Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Neurosci Res Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos